GIUSEPPE DI BELLA
>
INDICE DELLA DOCUMENTAZIONE > Area Pazienti - Documentazione
Area Pazienti - Documentazione
Pasireotide, an IGF-I action inhibitor,prevents growth hormone and estradiol-induced mammary hyperplasia.
(08/04/2011)
Dettaglio
Acromegaly: a review of current medical therapy and new drugs on the horizon.
(08/04/2011)
Dettaglio
Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: Results of a phase II study.
(08/04/2011)
Dettaglio
Increase in cytosolic calcium maintains plasma membrane integrity through the formation of microtubule ring structure in apoptotic cervical cancer cells induced by trichosanthin.
(08/04/2011)
Dettaglio
Regulation of PSA secretion and survival signaling by calcium-independent phopholipase A(2)beta in prostate cancer cells.
(08/04/2011)
Dettaglio
Somatostatin analogue inhibits the mobility of prostate carcinoma cells: a new
(08/04/2011)
Dettaglio
Can malignant bowel obstruction in advanced cancer patients be treated at home?
(08/04/2011)
Dettaglio
Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors.
(08/04/2011)
Dettaglio
Relationship between cytokeratin staining patterns and clinico-pathological features in
(08/04/2011)
Dettaglio
Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT.
(08/04/2011)
Dettaglio
Absence of somatostatin SST(2) receptor internalization in vivo after intravenous SOM230 application in the AR42J animal tumor model.
(08/04/2011)
Dettaglio
Palliative surgery versus medical management for bowel obstruction in ovarian cancer
(08/04/2011)
Dettaglio
Somatostatin and somatostatin receptors: from basic concepts to clinical applications.
(08/04/2011)
Dettaglio
A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models.
(08/04/2011)
Dettaglio
Does the response of GH-secreting pituitary adenomas to octreotide depend on the cellular localization of the somatostatin receptor subtypes SSTR2 and SSTR5?
(08/04/2011)
Dettaglio